Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimter MF 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimter MF 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as premature discontinuation, without medical consultation, risks elevated glucose levels and potential complications including kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headaches, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.

Primary Ingredients of Glimter MF 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glimter MF 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimter MF 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimter MF 1mg/500mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Glimter MF 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimter MF 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter MF 1mg/500mg Tablet SR whole; do not crush, chew, or fracture it. Administer this extended-release tablet with a meal.

How Glimter MF 1mg/500mg Tablet SR works:

Glimter MF SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimter MF 1mg/500mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Prolonged-release Glimter MF 1mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimter MF tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimter MF 1mg/500mg SR tablets; dosage modification may be necessary. Physician consultation is recommended. Glimter MF 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimter MF 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A low starting dose is typically recommended for those with mild to moderate liver disease; the medication is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimter MF 1mg/500mg Tablet SR :

Should you forget to take a Glimter MF 1mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimter MF 1mg/500mg Tablet SR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glimter MF 1mg/500mg Tablet SR

Maintain this medication within its original, sealed container. Follow storage guidelines as specified on the packaging. Discard any remaining medicine. Prevent access by children, pets, and others.
Glimter MF 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially dangerous side effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant quantities of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia warrant immediate cessation of Glimter MF 1mg/500mg Tablet SR use and prompt medical attention.
Glimepiride/Metformin 1mg/500mg extended-release tablets (Glimter MF) combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a suitable diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Glimter MF 1mg/500mg Tablets SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glimter MF 1mg/500mg Tablet SR can indeed lead to Vitamin B12 deficiency. This medication impairs the body's absorption of Vitamin B12 within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Indeed, Glimter MF 1mg/500mg SR tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol while taking Glimter MF 1mg/500mg Tablet SR is inadvisable due to the risk of dangerously low blood sugar (hypoglycemia). Furthermore, this combination elevates the likelihood of lactic acidosis.
Glimter MF 1mg/500mg Tabl...
43
MRP 52
17% off